Literature DB >> 18004331

HIV vaccine may raise risk.

Heidi Ledford.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18004331     DOI： 10.1038/450325a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Comparison of multiple vaccine vectors in a single heterologous prime-boost trial.

Authors:  Brice Barefoot; Natalie J Thornburg; Daniel H Barouch; Jae-Sung Yu; Christopher Sample; Robert E Johnston; Hua Xin Liao; Thomas B Kepler; Barton F Haynes; Elizabeth Ramsburg
Journal:  Vaccine       Date:  2008-09-20       Impact factor: 3.641

2.  Impact of ETIF deletion on safety and immunogenicity of equine herpesvirus type 1-vectored vaccines.

Authors:  Helga Hofmann-Sieber; Jens Wild; Nicole Fiedler; Karsten Tischer; Jens von Einem; Nikolaus Osterrieder; Heike Hofmann; Josef Köstler; Ralf Wagner
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

3.  TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8+ T Cell differentiation.

Authors:  Weiguo Cui; Nikhil S Joshi; Ying Liu; Hailong Meng; Steven H Kleinstein; Susan M Kaech
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

4.  Glycerol monolaurate prevents mucosal SIV transmission.

Authors:  Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase
Journal:  Nature       Date:  2009-03-04       Impact factor: 49.962

Review 5.  Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).

Authors:  Michael Vaine; Shan Lu; Shixia Wang
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

6.  A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection.

Authors:  Kejian Yang; Barbara J Whalen; Rebecca S Tirabassi; Liisa K Selin; Tatyana S Levchenko; Vladimir P Torchilin; Edward H Kislauskis; Dennis L Guberski
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

7.  Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.

Authors:  Petra Mooij; Sunita S Balla-Jhagjhoorsingh; Niels Beenhakker; Patricia van Haaften; Ilona Baak; Ivonne G Nieuwenhuis; Shirin Heidari; Hans Wolf; Marie-Joelle Frachette; Kurt Bieler; Neil Sheppard; Alexandre Harari; Pierre-Alexandre Bart; Peter Liljeström; Ralf Wagner; Giuseppe Pantaleo; Jonathan L Heeney
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

Authors:  Hung-Chih Yang; Sifei Xing; Liang Shan; Karen O'Connell; Jason Dinoso; Anding Shen; Yan Zhou; Cynthia K Shrum; Yefei Han; Jun O Liu; Hao Zhang; Joseph B Margolick; Robert F Siliciano
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

9.  CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections.

Authors:  Markus Cornberg; Shalyn C Clute; Levi B Watkin; Frances M Saccoccio; Sung-Kwon Kim; Yuri N Naumov; Michael A Brehm; Nuray Aslan; Raymond M Welsh; Liisa K Selin
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

10.  Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine.

Authors:  Katharina Böckl; Jens Wild; Simon Bredl; Kathrin Kindsmüller; Josef Köstler; Ralf Wagner
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.